A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection
Trial details
- Registry ID
- NCT05470387
- Drugs studied
- LB1148
TrialRedline tracks 2 clinical trials sponsored by Palisade Bio: 1 Phase 3, 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel ResectionNCT05470387 | LB1148 | Terminated | 2023-03-06Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel ResectionNCT02836470 | LB1148 | Completed | 2023-09-06Actual |
Names as written in the registry records.